Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Elicio Therapeutics (ELTX) Debt to Equity (2020 - 2026)

Elicio Therapeutics filings provide 1 years of Debt to Equity readings, the most recent being -$0.01 for Q4 2020.

  • On a quarterly basis, Debt to Equity changed N/A to -$0.01 in Q4 2020 year-over-year; TTM through Dec 2020 was -$0.01, a N/A change, with the full-year FY2020 number at -$0.01, changed N/A from a year prior.
  • Debt to Equity hit -$0.01 in Q4 2020 for Elicio Therapeutics.
  • In the past five years, Debt to Equity ranged from a high of -$0.01 in Q4 2020 to a low of -$0.01 in Q4 2020.